Academic Journal
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026.
| Τίτλος: | Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026. |
|---|---|
| Συγγραφείς: | Lee EK; Department of Internal Medicine, National Cancer Center, Goyang, Korea., Kang SH; Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Koo BS; Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Korea., Kim M; Department of Internal Medicine, Pusan National University Hospital, Busan, Korea., Kim MJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Kim BH; Department of Internal Medicine, Pusan National University Hospital, Busan, Korea., Kim JW; Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Korea., Na DG; Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea., Park S; Department of Nuclear Medicine, National Cancer Center, Goyang, Korea., Bang JI; Department of Nuclear Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea., Back K; Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea., Seo Y; Department of Nuclear Medicine, Chungnam National University Sejong Hospital, Sejong, Korea., Son YI; Department of Otolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Song YS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea., Shin DY; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Ahn JH; Department of Surgery, Chung-Ang University Hospital, Seoul, Korea., Ahn HY; Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea., Oh SW; Department of Nuclear Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea., Won HR; Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Korea., Yoo WS; Department of Internal Medicine, Dankook University Hospital, Cheonan, Korea., Lee MK; Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lee SW; Department of Nuclear Medicine, Kyungpook National University Chilgok Hospital, Daegu, Korea., Lee J; Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lee JY; Department of Radiology, Seoul National University Hospital, Seoul, Korea., Lim DJ; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Chung KW; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Chong A; Department of Nuclear Medicine, Chosun University Hospital, Gwangju, Korea., Jung JH; Department of Surgery, Kyungpook National University Chilgok Hospital, Daegu, Korea., Cho SW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Cho YY; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea., Hong CM; Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, Korea., Park YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. yjparkmd@snu.ac.kr. |
| Συλλογικό Έργο: | Korean Thyroid Association Guideline Committee on the Management of Thyroid Nodule and Cancer |
| Πηγή: | Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2026 Aug; Vol. 41 (4), pp. 493-534. Date of Electronic Publication: 2026 Aug 31. |
| Τύπος έκδοσης: | Journal Article; Practice Guideline |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2093-5978 (Electronic) Linking ISSN: 2093596X NLM ISO Abbreviation: Endocrinol Metab (Seoul) Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Seoul : Korean Endocrine Society, [2010]- |
| Ιατρικοί όροι (MeSH): | Thyroid Neoplasms*/therapy , Thyroid Neoplasms*/pathology , Thyroid Neoplasms*/diagnosis , Neoplasm Recurrence, Local*/diagnosis , Practice Guidelines as Topic*/standards, Thyrotropin/blood ; Humans ; Republic of Korea ; Prognosis ; Follow-Up Studies ; Risk Assessment ; Societies, Medical |
| Περίληψη: | In patients with differentiated thyroid cancer, initial recurrence-risk stratification based on clinical, histopathological, and perioperative findings remains central to management during the first 1-2 years after initial treatment. Ongoing risk stratification (ORS) complements this initial assessment by continuously integrating longitudinal clinical data and treatment response, thereby refining long-term prognostic assessment and supporting individualized risk-adapted management. Building on the 2024 Korean Thyroid Association (KTA) guidelines, the 2026 KTA guideline incorporates new evidence from large Korean multicenter cohorts and comprehensive systematic reviews. The updated recommendations reinforce the continued application of ORS and provide more specific guidance on risk-adapted thyroid-stimulating hormone (TSH) targets, surveillance strategies for recurrence detection, and long-term follow-up tailored to individual recurrence risk and treatment response. Consistent with the evolving paradigm toward risk-adapted and individualized management, this revision updates recommendations regarding target serum TSH levels, serum thyroglobulin thresholds for response assessment and long-term surveillance, and follow-up intervals based on both initial-risk category and the ORS response category. These evidence-based recommendations aim to minimize unnecessary treatment and excessive surveillance in the majority of patients who have an excellent prognosis after initial therapy while ensuring individualized long-term management for patients who require closer surveillance or additional therapeutic intervention. |
| References: | Eur J Nucl Med Mol Imaging. 2013 May;40(5):768-78. (PMID: 23242250) Ann Med. 2002;34(7-8):554-64. (PMID: 12553495) Exp Clin Endocrinol Diabetes. 2011 Jun;119(6):348-52. (PMID: 21264807) Diagnostics (Basel). 2021 Jul 14;11(7):. (PMID: 34359347) Endocrine. 2021 Aug;73(2):398-406. (PMID: 33570724) J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. (PMID: 36327392) Eur Radiol. 2022 Apr;32(4):2760-2768. (PMID: 34665316) Thyroid. 2023 Oct;33(10):1224-1236. (PMID: 37597200) Ann Nucl Med. 2012 Jan;26(1):77-85. (PMID: 22006540) N Engl J Med. 2001 Aug 16;345(7):512-6. (PMID: 11519506) Thyroid. 2017 Apr;27(4):524-530. (PMID: 27869547) J Clin Endocrinol Metab. 2003 Mar;88(3):1107-11. (PMID: 12629092) Endocrinol Metab (Seoul). 2025 Oct;40(5):759-771. (PMID: 40468888) Korean J Radiol. 2022 Oct;23(10):1019-1027. (PMID: 36098339) Eur Arch Otorhinolaryngol. 2016 Apr;273(4):1037-43. (PMID: 25744048) J Bone Metab. 2019 Feb;26(1):51-60. (PMID: 30899725) Thyroid. 2026 Jan;36(1):46-56. (PMID: 41467912) Clin Endocrinol (Oxf). 2002 Jul;57(1):117-24. (PMID: 12100079) Endocrinol Metab (Seoul). 2026 Aug;41(4):493-534. (PMID: 42705671) J Clin Endocrinol Metab. 2020 Aug 1;105(8):. (PMID: 32453405) J Clin Endocrinol Metab. 2014 Jun;99(6):1970-82. (PMID: 24617715) Thyroid. 2025 Feb;35(2):208-215. (PMID: 39723994) Nat Rev Endocrinol. 2014 Mar;10(3):164-74. (PMID: 24419358) Ann Nucl Med. 2023 Jan;37(1):18-25. (PMID: 36318362) Front Endocrinol (Lausanne). 2019 Nov 15;10:746. (PMID: 31803137) Cancers (Basel). 2022 Mar 13;14(6):. (PMID: 35326621) Endocrinol Metab (Seoul). 2019 Jun;34(2):150-157. (PMID: 31099202) Thyroid. 2022 Feb;32(2):138-144. (PMID: 34617446) Int J Endocrinol. 2013;2013:856189. (PMID: 23653645) Eur J Endocrinol. 2010 Aug;163(2):177-83. (PMID: 20484385) Thyroid. 2026 Apr;36(4):431-440. (PMID: 41841223) Thyroid. 2010 Dec;20(12):1341-9. (PMID: 21034228) Endocrine. 2024 Feb;83(2):251-258. (PMID: 37824045) J Clin Endocrinol Metab. 2010 Nov;95(11):4882-8. (PMID: 20660054) Ultrasonography. 2022 Jul;41(3):434-443. (PMID: 35189056) Clin Endocrinol (Oxf). 2005 Mar;62(3):376-9. (PMID: 15730423) J Clin Invest. 2016 Mar 1;126(3):1052-66. (PMID: 26878173) Nucl Med Mol Imaging. 2016 Jun;50(2):130-6. (PMID: 27275361) Arch Surg. 2004 Apr;139(4):390-4; discussion 393-4. (PMID: 15078706) JAMA Netw Open. 2019 Feb 1;2(2):e187754. (PMID: 30707227) J Clin Endocrinol Metab. 2010 Oct;95(10):4576-83. (PMID: 20660039) Thyroid. 2012 Aug;22(8):778-83. (PMID: 22780333) J Clin Endocrinol Metab. 2008 Apr;93(4):1167-9. (PMID: 18390811) Endocr Relat Cancer. 2016 Jan;23(1):47-52. (PMID: 26503963) J Clin Endocrinol Metab. 2020 Jun 1;105(6):. (PMID: 32219303) Head Neck. 2020 May;42(5):1004-1013. (PMID: 31930773) Clin Nucl Med. 2011 Feb;36(2):109-12. (PMID: 21220971) Korean J Radiol. 2022 Nov;23(11):1102-1111. (PMID: 36126955) Clin Hemorheol Microcirc. 2023;83(4):397-408. (PMID: 36683499) Ann Intern Med. 2003 Sep 2;139(5 Pt 1):346-51. (PMID: 12965943) Clin Endocrinol (Oxf). 2004 Jul;61(1):61-74. (PMID: 15212646) Front Oncol. 2022 Mar 14;12:852347. (PMID: 35359353) Endocrinol Metab (Seoul). 2023 Apr;38(2):175-189. (PMID: 37150514) Thyroid. 2011 Jul;21(7):691-2. (PMID: 21707434) Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2308652121. (PMID: 38175866) AJR Am J Roentgenol. 2001 Oct;177(4):929-36. (PMID: 11566708) J Am Coll Radiol. 2019 May;16(5S):S300-S314. (PMID: 31054756) Thyroid. 2014 Jan;24(1):7-18. (PMID: 24044517) Eur J Endocrinol. 2013 Nov 22;170(1):23-30. (PMID: 24088549) Clin Endocrinol (Oxf). 2011 Jul;75(1):112-9. (PMID: 21521273) Front Oncol. 2022 Jan 13;11:799956. (PMID: 35096601) Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):276-83. (PMID: 20091165) Thyroid. 2011 Dec;21(12):1317-22. (PMID: 22136267) Front Endocrinol (Lausanne). 2020 Jul 31;11:520. (PMID: 32849303) Surgery. 2011 Dec;150(6):1250-7. (PMID: 22136848) Surgery. 2018 Jan;163(1):75-80. (PMID: 29122328) Thyroid. 2012 Aug;22(8):832-8. (PMID: 22853728) Thyroid. 2012 Aug;22(8):784-90. (PMID: 22780573) Eur Thyroid J. 2017 Nov;6(6):292-297. (PMID: 29234622) J Clin Endocrinol Metab. 2019 Nov 1;104(11):4981-4989. (PMID: 31206157) Thyroid. 2010 Feb;20(2):135-46. (PMID: 20151821) Cancers (Basel). 2021 Mar 16;13(6):. (PMID: 33809585) J Clin Endocrinol Metab. 2025 Nov 18;110(12):3588-3598. (PMID: 40811629) Eur J Endocrinol. 2011 Sep;165(3):441-6. (PMID: 21750043) J Clin Endocrinol Metab. 2012 Jul;97(7):2380-7. (PMID: 22539585) J Endocrinol Invest. 2019 Oct;42(10):1223-1230. (PMID: 30963467) Anticancer Res. 2022 Nov;42(11):5619-5627. (PMID: 36288865) Eur J Endocrinol. 2005 Jul;153(1):49-55. (PMID: 15994745) Endocrinol Metab (Seoul). 2021 Jun;36(3):574-581. (PMID: 34034365) Cytojournal. 2008 Jan 31;5:1. (PMID: 18237420) Thyroid. 2009 Nov;19(11):1145-7. (PMID: 19888856) J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53. (PMID: 22679061) J Clin Endocrinol Metab. 2012 Aug;97(8):2754-63. (PMID: 22639291) Thyroid. 2015 Mar;25(3):300-7. (PMID: 25386760) Front Oncol. 2021 Nov 29;11:764258. (PMID: 34912712) Endocr Relat Cancer. 2005 Jun;12(2):273-80. (PMID: 15947102) Cancers (Basel). 2022 Apr 23;14(9):. (PMID: 35565235) Thyroid. 2012 May;22(5):482-6. (PMID: 22175271) Curr Opin Endocrinol Diabetes Obes. 2023 Oct 1;30(5):238-243. (PMID: 37470486) Thyroid. 2018 Aug;28(8):997-1003. (PMID: 29845894) J Clin Endocrinol Metab. 2005 Sep;90(9):5047-57. (PMID: 15972576) Endocr Pract. 2013 Nov-Dec;19(6):1015-20. (PMID: 24013973) Rev Endocr Metab Disord. 2024 Feb;25(1):79-93. (PMID: 38015344) Surg Pathol Clin. 2023 Mar;16(1):45-56. (PMID: 36739166) J Endocrinol Invest. 2011 Sep;34(8):e219-23. (PMID: 21399390) Cancers (Basel). 2022 Oct 08;14(19):. (PMID: 36230856) Eur J Endocrinol. 2008 May;158(5):691-8. (PMID: 18426828) Thyroid. 2002 May;12(5):411-9. (PMID: 12097203) Thyroid. 2006 Jun;16(6):583-91. (PMID: 16839260) J Clin Endocrinol Metab. 2017 Mar 1;102(3):893-902. (PMID: 27929713) Eur Thyroid J. 2021 Jun;10(3):198-207. (PMID: 34178705) Best Pract Res Clin Endocrinol Metab. 2013 Oct;27(5):701-12. (PMID: 24094640) Clin Endocrinol (Oxf). 2012 Apr;76(4):586-92. (PMID: 22059804) Lancet Diabetes Endocrinol. 2022 May;10(5):366-372. (PMID: 35240052) J Endocrinol Invest. 2018 Jul;41(7):849-876. (PMID: 29729004) Endocrinol Metab Clin North Am. 2019 Mar;48(1):227-237. (PMID: 30717904) J Clin Endocrinol Metab. 2012 Aug;97(8):2706-13. (PMID: 22639292) Int J Surg. 2015 Apr;16(Pt A):107-112. (PMID: 25771100) Medicine (Baltimore). 2019 Nov;98(45):e17859. (PMID: 31702649) Korean J Radiol. 2021 May;22(5):840-860. (PMID: 33660459) J Clin Endocrinol Metab. 2010 May;95(5):2187-94. (PMID: 20332244) Thyroid. 2025 Aug;35(8):841-985. (PMID: 40844370) Eur J Endocrinol. 2013 Oct 04;169(5):689-93. (PMID: 23939918) Endocrinol Metab (Seoul). 2023 Feb;38(1):104-116. (PMID: 36891657) Thyroid. 2021 Sep;31(9):1383-1390. (PMID: 33779292) Clin Endocrinol (Oxf). 2011 Jan;74(1):111-7. (PMID: 21054476) Thyroid. 2018 Oct;28(10):1311-1317. (PMID: 30105948) Clin Endocrinol (Oxf). 2012 Jul;77(1):132-8. (PMID: 22248037) J Thyroid Res. 2013;2013:398194. (PMID: 24455413) Eur J Endocrinol. 2019 Aug;181(2):93-102. (PMID: 31117054) Int J Endocrinol. 2014;2014:591285. (PMID: 25114681) Front Oncol. 2021 May 13;11:648658. (PMID: 34055616) Thyroid. 2017 Nov;27(11):1400-1407. (PMID: 28847226) Ann Oncol. 2019 Dec 1;30(12):1856-1883. (PMID: 31549998) Thyroid. 2017 Apr;27(4):531-536. (PMID: 28007013) Korean J Radiol. 2021 Dec;22(12):2094-2123. (PMID: 34719893) Eur J Endocrinol. 2014 Jun;170(6):837-46. (PMID: 24659355) Clin Endocrinol (Oxf). 2022 Jul;97(1):130-136. (PMID: 35174522) Br J Surg. 1990 Mar;77(3):324-6. (PMID: 2322802) Thyroid. 2024 Nov;34(11):1346-1355. (PMID: 39283820) J Clin Endocrinol Metab. 2004 Jul;89(7):3402-7. (PMID: 15240622) Endocr Relat Cancer. 2021 Apr;28(4):R111-R119. (PMID: 33690160) Clin Endocrinol (Oxf). 2018 Jul;89(1):100-109. (PMID: 29672893) Thyroid. 2022 Jun;32(6):613-639. (PMID: 35412871) BMC Clin Pathol. 2013 Feb 19;13:7. (PMID: 23421519) J Clin Endocrinol Metab. 2021 Nov 19;106(12):3655-3667. (PMID: 34302730) J Clin Endocrinol Metab. 2011 Jul;96(7):2049-56. (PMID: 21508143) J Clin Endocrinol Metab. 2024 Jan 18;109(2):e765-e772. (PMID: 37656124) J Clin Endocrinol Metab. 2015 Sep;100(9):3270-9. (PMID: 26171797) BMJ Open. 2021 May 13;11(5):e043007. (PMID: 33986046) Eur Thyroid J. 2013 Sep;2(3):147-59. (PMID: 24847448) Endocr Relat Cancer. 2011 Mar 03;18(2):R29-40. (PMID: 21183629) Thyroid. 2011 Aug;21(8):845-53. (PMID: 21809914) J Clin Endocrinol Metab. 2002 Apr;87(4):1499-501. (PMID: 11932271) Endocr Relat Cancer. 2019 Oct;26(10):R553-R566. (PMID: 31394499) Clin Nucl Med. 2024 Mar 1;49(3):215-225. (PMID: 38048517) Endocrinol Metab (Seoul). 2024 Feb;39(1):188-189. (PMID: 38311827) Endocrinol Metab Clin North Am. 2014 Jun;43(2):401-21. (PMID: 24891169) Endocrine. 2020 Dec;70(3):552-557. (PMID: 32653994) Diagn Interv Imaging. 2021 Sep;102(9):515-523. (PMID: 33926848) Endocrinol Metab Clin North Am. 2008 Jun;37(2):419-35, ix-x. (PMID: 18502335) Horm Metab Res. 2023 Jun;55(6):379-387. (PMID: 37295414) Lancet Diabetes Endocrinol. 2018 Aug;6(8):618-626. (PMID: 29807824) Endocrinol Metab (Seoul). 2022 Aug;37(4):652-663. (PMID: 35864728) J Clin Endocrinol Metab. 2008 Dec;93(12):4683-9. (PMID: 18812478) J Clin Endocrinol Metab. 2013 Mar;98(3):1061-8. (PMID: 23393171) Laryngoscope Investig Otolaryngol. 2021 Dec 24;7(1):274-282. (PMID: 35155808) J Clin Endocrinol Metab. 2011 Dec;96(12):3615-27. (PMID: 21917876) PLoS One. 2019 Jun 25;14(6):e0218416. (PMID: 31237886) J Clin Endocrinol Metab. 2008 Mar;93(3):809-14. (PMID: 18160464) J Clin Endocrinol Metab. 2016 Jul;101(7):2692-700. (PMID: 27023446) J Clin Endocrinol Metab. 1998 Apr;83(4):1121-7. (PMID: 9543128) J Ultrasound Med. 2003 Oct;22(10):1126-30. (PMID: 14606572) Thyroid. 2016 Jan;26(1):1-133. (PMID: 26462967) J Clin Oncol. 2013 Nov 10;31(32):4046-53. (PMID: 24101052) Clin Chem Lab Med. 2022 Jan 28;60(5):756-765. (PMID: 35108464) Clin Imaging. 2008 Jan-Feb;32(1):32-7. (PMID: 18164392) Endocr Pract. 2019 Feb;25(2):165-169. (PMID: 30383494) Radiology. 2021 May;299(2):374-380. (PMID: 33650902) Clin Endocrinol (Oxf). 2009 Jan;70(1):145-51. (PMID: 18466347) Thyroid. 2021 Sep;31(9):1391-1399. (PMID: 34340593) J Clin Endocrinol Metab. 2008 Jan;93(1):76-81. (PMID: 17971424) Thyroid. 2013 Oct;23(10):1211-25. (PMID: 23692026) Acta Endocrinol (Buchar). 2021 Jul-Sep;17(3):337-345. (PMID: 35342477) J Clin Endocrinol Metab. 2021 Jul 13;106(8):2355-2366. (PMID: 33901285) Thyroid. 2015 Jan;25(1):3-14. (PMID: 25188202) Clin Endocrinol (Oxf). 2018 Feb;88(2):303-310. (PMID: 29154445) Thyroid. 2024 Jun;34(6):674-686. (PMID: 38717947) Ann Surg Treat Res. 2024 Jan;106(1):19-30. (PMID: 38205091) Laryngoscope. 2008 May;118(5):768-75. (PMID: 18197134) Korean J Radiol. 2020 May;21(5):598-604. (PMID: 32323505) Endocrinol Metab (Seoul). 2025 Jun;40(3):357-384. (PMID: 40598904) J Clin Endocrinol Metab. 2021 Nov 19;106(12):3644-3654. (PMID: 34347085) Eur Thyroid J. 2016 Mar;5(1):44-9. (PMID: 27099838) J Clin Endocrinol Metab. 1996 Dec;81(12):4224-8. (PMID: 8954019) Thyroid. 2017 Feb;27(2):174-181. (PMID: 27750028) Ann Nucl Med. 2014 Apr;28(3):241-7. (PMID: 24379008) Thyroid. 2011 Jul;21(7):707-16. (PMID: 21649472) Thyroid. 2020 Nov;30(11):1601-1612. (PMID: 32345152) Clin Otolaryngol. 2018 Aug;43(4):1065-1072. (PMID: 29575557) |
| Grant Information: | Korean Thyroid Association; 2112570 National Cancer Care Guideline Research Grant; RS-2024-00398702 Patient-Centered Clinical Research Coordinating Center; Ministry of Health and Welfare |
| Contributed Indexing: | Keywords: Differentiated thyroid cancer; Guideline; Ongoing risk stratification; Surveillance; Thyroid-stimulating hormone target |
| Substance Nomenclature: | 9002-71-5 (Thyrotropin) |
| Entry Date(s): | Date Created: 20260907 Date Completed: 20260907 Latest Revision: 20260917 |
| Update Code: | 20260917 |
| PubMed Central ID: | PMC13555224 |
| DOI: | 10.3803/EnM.2026.3149 |
| PMID: | 42705671 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!